UTHR
United Therapeutics Corporation
Stock
$541.70−29.68 (−5.19%)Close Oct 2, 2026
- Revenue, 2025
- $3.2B
- YoY, 2025
- +10.6%
- 5-year CAGR
- +16.5%
- 10-year CAGR
- +8.1%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $3.2B | +10.6% |
| 2024 | $2.9B | +23.6% |
| 2023 | $2.3B | +20.2% |
| 2022 | $1.9B | +14.9% |
| 2021 | $1.7B | +13.6% |
| 2020 | $1.5B | +2.4% |
| 2019 | $1.4B | −11.0% |
| 2018 | $1.6B | −5.7% |
| 2017 | $1.7B | +7.9% |
| 2016 | $1.6B | +9.1% |
| 2015 | $1.5B | +13.8% |
| 2014 | $1.3B | +15.4% |
| 2013 | $1.1B | +21.9% |
| 2012 | $916M | +23.3% |
| 2011 | $743M | +25.3% |
| 2010 | $593M | +65.2% |
| 2009 | $359M | +27.5% |
| 2008 | $281M | — |